The FDA provided 510(k) clearance on Thursday to Intuitive Surgical, Inc.’s (NASDAQ:ISRG) Da Vinci 5, the company’s next-generation multiport robotic system.
Surgeons and care teams worldwide have used the Da Vinci 5 surgical system in over 7 million procedures.
The company placed 415 Da Vinci surgical systems in the fourth quarter of 2023, compared with 369 systems in the fourth quarter of 2022.
The system includes more than 150 enhancements, including:
- Da Vinci 5’s Force Feedback technology and optional instruments enable the system to measure and surgeons to feel subtle forces exerted on tissue during surgery. In preclinical trials with surgeons at all experience ...